In Q2 fiscal 2026 (the quarter ended June 30, 2026), Natera's largest product or service was Product, with $747.93 million or 99% of revenue, up 37.4% from a year earlier. Next: Licensing and Other (1%).
By region, United States brought in 98%, EMEA brought in 1% and Americas, Excluding United States brought in under 1% of revenue in Q2 fiscal 2026.
By customer type, Insurance Carriers brought in 94%, Laboratory Partners brought in 5% and Patients brought in 1% of revenue in Q2 fiscal 2026.
From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q3 fiscal 2017.

Fiscal quarters, from company filings
| Product or service | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Product | $747.9M | $693.9M | $590.2M | $544.4M | 99% |
| Licensing and Other | $4.8M | $2.8M | – | $2.2M | 1% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
| Region | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| United States | $739.5M | $685.6M | $582.4M | $537.8M | 98% |
| EMEA | $9.0M | $6.4M | $6.0M | $5.4M | 1% |
| Americas, Excluding United States | $2.2M | $2.4M | – | $1.6M | under 1% |
| Asia Pacific and Other | $2.0M | $2.2M | $2.3M | $1.8M | under 1% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
| Customer type | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Insurance Carriers | $705.1M | $658.1M | – | $517.0M | 94% |
| Laboratory Partners | $37.7M | $28.8M | – | $22.2M | 5% |
| Patients | $9.9M | $9.7M | $7.6M | $7.4M | 1% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Product: $747.93 million, or 99% of revenue, in Q2 fiscal 2026.
By revenue in Q2 fiscal 2026: Product (99%) and Licensing and Other (1%).
By region in Q2 fiscal 2026: United States (98%), EMEA (1%), Americas, Excluding United States (under 1%) and Asia Pacific and Other (under 1%).
Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i
Fiscal quarter ended Jun 30, 2026
| Item | Revenue | Share |
|---|---|---|
| Reportable | USD 752.75M | 100.0% |
Sum of items USD 752.75M. Shares are of the items shown. Click an item with › to see its parts.
Every item and period in one grid. Purple = calculated; "–" = not available.
| Item | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Reportable | 752.8M | 696.6M | – | – | 546.6M | 501.8M | – | – | – | – |
| Single | – | – | – | 592.2M | – | – | 476.1M | 439.8M | 413.4M | 367.7M |